Future research may involve integrating postoperative sCEA, recurrence CEA (rCEA), faecal CEA, CA199, CA724, and other tumour biomarkers with tCEA or preoperative sCEA to further investigate their prognostic roles and mitigate the limitations associated with single biomarker testing. The gene discussed is CEACAM5; the disease is neoplasm.